期刊文献+

惠州市耐药结核病筛查结果分析 被引量:9

Analysis on the screening results of drug- resistant tuberculosis in Huizhou City
原文传递
导出
摘要 目的了解惠州市肺结核患者的耐药筛查情况。方法对2009-2014年全球基金结核病防治项目实施期间全市涂阳肺结核患者的耐药检测结果进行分析。结果 (1)全市登记涂阳患者耐药筛查率21.66%。其中初治涂阳患者筛查率18.80%;复治涂阳患者筛查率41.56%。(2)涂阳患者耐药率46.63%、耐多药率16.34%。初、复治涂阳患者耐药率38.37%、71.30%和耐多药率7.96%、41.36%。初、复治涂阳患者耐药率、耐多药差异有统计学意义(χ2=105.75、197.95,P<0.01)。(3)对4种一线抗结核药物的耐药顺位(耐药率)由高至低是链霉素(S,32.0%)、异烟肼(H,25.49%)、利福平(R,21.02%)和乙胺丁醇(E,15.29%),耐多药以耐4种药物的最多(8.39%),其次是耐HR(3.14%)、耐HRE(2.35%)以及耐HRS(2.27%)。结论惠州市结核病患者耐药筛查率较低,对1 291例菌株的耐药分析显示耐药率、耐多药率偏高。今后应继续加大耐药结核病筛查力度、加强结核病实验质量控制,提高全市耐药结核病防治效果。 Objective To explore the screening results of drug- resistant pulmonary tuberculosis in Huizhou City. Methods The drug- resistant data of pulmonary tuberculosis cases enrolled in the Global Fund Project from 2009 to 2014 in Huizhou City were analyzed. Results The overall drug resistance screening rate of the smear- positive pulmonary tuberculosis patients in Huizhou City was 21. 66%,with 18. 80% for new patients and 41. 56% for retreatment patients. The overall drug- resistant rates and the multidrug- resistant rates of the smear- positive pulmonary tuberculosis patients were 46. 63% and 16. 34% respectively.Statistical difference could be found between new patients and retreatment patients not only in drug resistant rate( 38. 37% vs. 71.30%,χ2= 105. 75,P 〈0. 01),but also in multidrug resistant rate( 7. 96% vs. 41. 36%,χ2= 197. 95,P〈 0. 01). The drug- resistant spectrum in descending sequence was streptomycin( S,32. 0%),isoniazide( H,25. 49%),rifampicin( R,21. 02%) and ethambutol( E,15. 29%). The multidrug- resistant spectrum in descending sequence was HRES( 8. 39%),HR( 3. 14%),HRE( 2. 35%) and HRS( 2. 27%). Conclusions The resistance screening rate of the smear- positive pulmonary tuberculosis patients in Huizhou City is low. The overall drug- resistant rate and multidrug- resistant rate are relatively high in the 1,291 cases.Improving the drug resistant screening and intensifying the quality control of tuberculosis laboratory are strongly recommended to facilitate tuberculosis control in Huizhou City.
出处 《实用预防医学》 CAS 2015年第5期527-530,共4页 Practical Preventive Medicine
基金 中国全球基金结核病项目(CHN-S10-G14-T) 2013年惠州市科技计划项目(医疗卫生)(2013Y107)
关键词 肺结核 分枝杆菌 耐药 筛查 Pulmonary tuberculosis Mycobacterium tuberculosis Drug resistance Screening
  • 相关文献

参考文献5

二级参考文献25

  • 1谢运娥,萧瑞球.结核患者对健康教育需求的调查与分析[J].临床肺科杂志,2007,12(5):502-502. 被引量:7
  • 2王甦民,刘宇红,姜广路,刘洋,付育红,端木宏谨.世界卫生组织中国结核病耐药监测的结果评价[J].中华检验医学杂志,2007,30(8):863-866. 被引量:48
  • 3中华人民共和国卫生部.全国结核病耐药性基线调查报告(2007-2008年).北京:人民卫生出版社,2010:1-8.
  • 4World Health Organization. Guidelines for surveillance of drug resistance in tuberculosis[R]. 4th ed. Geneva: WHO, 2009.422.
  • 5Singh MM, Chopra KK. MDR- TB current issue[J]. Indian J Tubert, 2004,51(1): 1-3.
  • 6World Health Organization. Guidelines for the programmatic management of drug- resistant tuberculosis [M]. Geneva: WHO, 2006. 361.
  • 7World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis (emergency update 2008) [M/OL]. Geneva: WHO, 2008:3-13 1-2011-6-201. http://whqlibdoc, who. int/publications/2008/9789241547581_ eng. pdf.
  • 8Menzies D, Benedetti A, Paydar A, et al. Effect of duration and intermittency of rifampin on tuberculosis treatment out- comes: a systematic review and meta-analysis. PLoS Med, 2009, 6(9) :e1000146.
  • 9World Health Organization. Treatment of tuberculosis: guide- lines-4th ed[M/OL]. Geneva: WHO, 2010: aa-a512011-6-203. http://whqlibdoc, who. int/publications/2010/9789241547833_ eng. pdf.
  • 10Nathanson E, Lambregts-van Weezenbeek C, Rich ML, et al. Multidrug-resistant tuberculosis management in resource-limit- ed settings. Emerg Infect Dis,2006,12(9) : 1389-1397.

共引文献60

同被引文献71

引证文献9

二级引证文献61

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部